Sat 28 Nov 2009 | 4:03 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Repligen Corp

Repligen Corp (RGEN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View RGEN on other exchanges
As of  27 Nov 2009
4.65USD
Price Change
-0.07
Percent Change
-1.48%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Witt, Daniel 62 2005 Vice President - Operations
Rusche, James 55 2001 Senior Vice President - Research and Development
Herlihy, Walter 57 1996 President, Chief Executive Officer, Director
Ryan, Thomas 68 2003 Director
Dawes, Karen 57 2005 Director
Henry, Earl 62 2007 Director
Goldberg, Alfred 66 2008 Director
Cooper, Glenn 56 2009 Director
Kelly, William 38 2009 Chief Financial Officer
Rich, Alexander 84 -- Chairman of the Board